{"id":6837,"date":"2025-02-24T16:07:18","date_gmt":"2025-02-24T16:07:18","guid":{"rendered":"https:\/\/stoxpo.com\/?p=6837"},"modified":"2025-02-24T16:07:19","modified_gmt":"2025-02-24T16:07:19","slug":"hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/","title":{"rendered":"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Hims &amp; Hers Health (HIMS) is at a crossroads as it prepares to report earnings after Monday\u2019s market close. The telehealth company\u2019s stock, which has surged 458% since announcing its move into weight-loss treatments in December 2023, saw a sharp pullback on Friday after regulators removed a key advantage for its business.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Food and Drug Administration (FDA) declared the shortage of Novo Nordisk\u2019s (NVO) Wegovy and Ozempic over, revoking permission for compounding pharmacies to produce copycat versions. The decision sent Hims &amp; Hers shares tumbling 26% as investors questioned whether its compounding strategy would hold up under legal scrutiny.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Despite the setback, retail traders have driven Hims &amp; Hers into meme-stock territory, reminiscent of past frenzies around GameStop (GME) and AMC Entertainment (AMC). The stock gained traction after a bold ad campaign\u2014featured during the Super Bowl\u2014that criticized the U.S. healthcare system while promoting the company\u2019s weight-loss offerings.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Short sellers have ramped up bets against the stock, with shares out on loan rising to 33% from 14% in October, according to S3 Partners. Options traders are also bracing for volatility, with contracts pricing in a massive 24.1% move post-earnings, far exceeding the stock\u2019s historical average swing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Wall Street analysts remain cautious. Hims &amp; Hers trades at 45 times estimated earnings\u2014higher than obesity drug leader Eli Lilly (LLY). Analysts expect a strong fourth-quarter report, with profit projected to soar 929% and sales up 91%, but a miss could send the stock plummeting.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With high expectations and increased scrutiny, Monday\u2019s earnings report could determine whether Hims &amp; Hers sustains its rally or faces a harsh reality check.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"> <a href=\"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/robinhood-cleared-in-sec-crypto-probe-amid-regulatory-shift\/\">Robinhood Cleared in SEC Crypto Probe Amid Regulatory Shift<\/a><\/mark><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism Hims &amp; Hers Health (HIMS) is at a crossroads as it prepares to report earnings after Monday\u2019s market close. The telehealth company\u2019s stock, which has surged 458% since announcing its move into weight-loss treatments in December 2023, saw a sharp pullback on Friday after regulators removed [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3001,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"0","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"0","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[360,309],"tags":[421,662,661,416,418,417],"coauthors":[454],"class_list":["post-6837","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mid-cap","category-pharmaceuticals","tag-growth","tag-hims","tag-meme-stocks","tag-movers","tag-news","tag-stock-market"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism Hims &amp; Hers Health (HIMS) is at a crossroads as it prepares to report earnings after Monday\u2019s market close. The telehealth company\u2019s stock, which has surged 458% since announcing its move into weight-loss treatments in December 2023, saw a sharp pullback on Friday after regulators removed [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T16:07:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T16:07:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/05\/pexels-anna-nekrashevich-6801647.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1279\" \/>\n\t<meta property=\"og:image:height\" content=\"918\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luca Blaumann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luca Blaumann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/\"},\"author\":{\"name\":\"Luca Blaumann\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\"},\"headline\":\"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility\",\"datePublished\":\"2025-02-24T16:07:18+00:00\",\"dateModified\":\"2025-02-24T16:07:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/\"},\"wordCount\":300,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/pexels-anna-nekrashevich-6801647.jpg\",\"keywords\":[\"Growth\",\"HIMS\",\"Meme Stocks\",\"Movers\",\"News\",\"Stock Market\"],\"articleSection\":[\"Mid-Cap\",\"Pharmaceuticals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/\",\"name\":\"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/pexels-anna-nekrashevich-6801647.jpg\",\"datePublished\":\"2025-02-24T16:07:18+00:00\",\"dateModified\":\"2025-02-24T16:07:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/pexels-anna-nekrashevich-6801647.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/pexels-anna-nekrashevich-6801647.jpg\",\"width\":1279,\"height\":918,\"caption\":\"investing\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2025\\\/02\\\/24\\\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\",\"name\":\"Luca Blaumann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"caption\":\"Luca Blaumann\"},\"description\":\"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/luca-blaumann\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/","og_locale":"en_US","og_type":"article","og_title":"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility - Stoxpo","og_description":"Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism Hims &amp; Hers Health (HIMS) is at a crossroads as it prepares to report earnings after Monday\u2019s market close. The telehealth company\u2019s stock, which has surged 458% since announcing its move into weight-loss treatments in December 2023, saw a sharp pullback on Friday after regulators removed [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/","og_site_name":"Stoxpo","article_published_time":"2025-02-24T16:07:18+00:00","article_modified_time":"2025-02-24T16:07:19+00:00","og_image":[{"width":1279,"height":918,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/05\/pexels-anna-nekrashevich-6801647.jpg","type":"image\/jpeg"}],"author":"Luca Blaumann","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Luca Blaumann","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/"},"author":{"name":"Luca Blaumann","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806"},"headline":"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility","datePublished":"2025-02-24T16:07:18+00:00","dateModified":"2025-02-24T16:07:19+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/"},"wordCount":300,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/05\/pexels-anna-nekrashevich-6801647.jpg","keywords":["Growth","HIMS","Meme Stocks","Movers","News","Stock Market"],"articleSection":["Mid-Cap","Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/","url":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/","name":"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/05\/pexels-anna-nekrashevich-6801647.jpg","datePublished":"2025-02-24T16:07:18+00:00","dateModified":"2025-02-24T16:07:19+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/05\/pexels-anna-nekrashevich-6801647.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/05\/pexels-anna-nekrashevich-6801647.jpg","width":1279,"height":918,"caption":"investing"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2025\/02\/24\/hims-hers-health-faces-crucial-earnings-test-amid-stock-volatility\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Hims &amp; Hers Health Faces Crucial Earnings Test Amid Stock Volatility"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806","name":"Luca Blaumann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b","url":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","caption":"Luca Blaumann"},"description":"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/luca-blaumann\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/6837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=6837"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/6837\/revisions"}],"predecessor-version":[{"id":6839,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/6837\/revisions\/6839"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/3001"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=6837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=6837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=6837"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=6837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}